Amevive Side Effects
Generic Name: alefacept
Note: This document contains side effect information about alefacept. Some of the dosage forms listed on this page may not apply to the brand name Amevive.
For the Consumer
Applies to alefacept: intramuscular powder for solution
Along with its needed effects, alefacept (the active ingredient contained in Amevive) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking alefacept:
- lower back or side pain
- painful or difficult urination
- Body aches or pain
- dryness or soreness of the throat
- runny nose
- tender, swollen glands in the neck
- trouble with swallowing
- voice changes
- Arm, back, or jaw pain
- chest pain or discomfort
- chest tightness or heaviness
- fast or irregular heartbeat
- pain or discomfort in the arms, jaw, back, or neck
- shortness of breath
Some side effects of alefacept may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Pain, swelling, bleeding, skin rash, or lumps at the injection site
- Difficulty with moving
- itching skin
- joint pain
- muscle aching or cramping
- muscle pains or stiffness
- swollen joints
For Healthcare Professionals
Applies to alefacept: intramuscular powder for injection, intravenous powder for injection
Immunologic side effects including dose-dependent reductions in circulating CD4+ and CD8+ T lymphocyte counts have been reported.[Ref]
The total percentage of alefacept-treated patients hospitalized for cardiovascular events was 1.2%.[Ref]
Cardiovascular side effects including coronary artery disorder (<1%) and myocardial infarction (<1%) have been the adverse reactions which most commonly resulted in clinical intervention.[Ref]
Twenty five of the 1,357 patients who received alefacept (the active ingredient contained in Amevive) were diagnosed with a total of 35 treatment-emergent malignancies. Six cases were basal cell and seventeen cases were squamous cell cancers of the skin. Three cases of lymphoma have been reported; one was classified as non-Hodgkin's follicle-center cell lymphoma and two were classified as Hodgkin's disease.[Ref]
Oncologic side effects including malignancies have been reported. Postmarketing reports of malignancies including skin, solid organ, lymphomas and leukemias have also been received.[Ref]
Chills have been reported to occur predominantly with intravenous administration.[Ref]
General side effects including chills (6%), dizziness, headache, and accidental injury have been reported. Postmarketing reports of sepsis and opportunistic infections (viral, fungal, and bacterial) have been received.[Ref]
Local side effects including injection site pain and injection site inflammation have been reported.[Ref]
Musculoskeletal side effects including myalgia have been reported.[Ref]
Hepatic side effects including postmarketing reports of asymptomatic transaminase elevation, fatty infiltration of the liver, hepatitis, and severe liver failure have been received.
Genitourinary side effects including postmarketing reports of urinary tract infection have been received.
1. "Product Information. Amevive (alefacept)." Biogen, Cambridge, MA.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
More about Amevive (alefacept)
- During Pregnancy
- Dosage Information
- Drug Interactions
- 1 Review
- Drug class: selective immunosuppressants